Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
24.62
-1.10 (-4.28%)
At close: Aug 29, 2025, 4:00 PM
24.62
0.00 (0.00%)
After-hours: Aug 29, 2025, 4:00 PM EDT

Sionna Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Selling, General & Admin
19.813.279.716.77
Research & Development
67.8957.2940.6334.61
Operating Expenses
87.6870.5650.3341.37
Operating Income
-87.68-70.56-50.33-41.37
Interest & Investment Income
11.148.172.771.13
Other Non Operating Income (Expenses)
0.70.70.3-
Pretax Income
-75.84-61.69-47.26-40.24
Net Income
-75.84-61.69-47.26-40.24
Net Income to Common
-75.84-61.69-47.26-40.24
Shares Outstanding (Basic)
20433
Shares Outstanding (Diluted)
20433
Shares Change (YoY)
581.87%31.56%13.80%-
EPS (Basic)
-3.79-15.99-16.11-15.61
EPS (Diluted)
-3.79-15.99-16.11-15.61
Free Cash Flow
-64.02-52.81-44.82-37.94
Free Cash Flow Per Share
-3.20-13.69-15.28-14.72
EBITDA
-87.04-69.89-49.75-41.25
D&A For EBITDA
0.640.670.580.12
EBIT
-87.68-70.56-50.33-41.37
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q